Genesis Swaps Software Rights for Stake in Real Time Genomics | GenomeWeb

NEW YORK (GenomeWeb News) — Genesis Research and Development will trade its rights to royalties on the sale of a genomics data querying software package for a stake in start-up bioinformatics company Real Time Genomics.

Auckland, New Zealand-based Genesis said today that it is converting the royalty rights to NetValue's SLIM Search software, which is based on Genesis' Cartesian technology, in exchange for a 10 percent stake in the Real Time Genomics. Genesis' interest will be held by New Zealand holding company Gene Value.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.